Article

Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing <i>PPARA</i>

2021-06-07

Abstract excerpt

<h4>Background</h4> Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive lipid accumulation and imbalances in lipid metabolism in the liver. Although nuclear receptors (NRs) play a crucial role in hepatic lipid metabolism, the underlying mechanisms of NR regulation in NAFLD remain largely unclear. <h4>Methods</h4> Using network analysis and RNA-seq to determine the correlation between NRs and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 414f4c3e-3b9e-5799-a46e-fac1a671a16a
DOI: 10.1101/2021.06.07.447348

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing <i>PPARA</i>DOI 10.1101/2021.06.07.447348Read

Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b PathwaySemantic proximity Read

Effect of miRNA‐10b in regulating cellular steatosis level by targeting PPAR‐α expression, a novel mechanism for the pathogenesis of NAFLDSemantic proximity Read

Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARsSemantic proximity Read

SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic StrategiesSemantic proximity Read

Regulation of fatty acid oxidation by liraglutide via SIRT1 in hepatocytes: A mechanistic studySemantic proximity Read

LncNONMMUG027912 alleviates lipid accumulation through AMPKα/mTOR/SREBP1C axis in nonalcoholic fatty liverSemantic proximity Read

mmu_circ_0009303 improves nonalcoholic fatty liver disease by regulating lipid metabolism and oxidative stress in vivo and in vitroSemantic proximity Read

miR-21: A therapeutic target for delaying severe liver disease and hepatocellular carcinoma in high-fat-diet-fed miceSemantic proximity Read

Fat Mass and Obesity–Associated Protein Promotes Liver Steatosis By Targeting PPARαSemantic proximity Read

IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental studySemantic proximity Read

Enpp1 ameliorates NAFLD by regulating hepatocyte lipid metabolism through the AMPK/PPARα signaling pathwaySemantic proximity Read

Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2Semantic proximity Read